RARRES2 and pulmonary fibrosis: Genetically engineered RARRES2−/− (chemerin-deficient) and CMKLR1−/− mice have been used to study metabolic and inflammatory diseases [40], but there is a paucity of data examining their response to bleomycin- or silica-induced lung fibrosis.